Lacayo NJ - Search Results

1

Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes.

Lacayo NJ, Meshinchi S, Kinnunen P, Yu R, Wang Y, Stuber CM, Douglas L, Wahab R, Becton DL, Weinstein H, Chang MN, Willman CL, Radich JP, Tibshirani R, Ravindranath Y, Sikic BI, Dahl GV. Lacayo NJ, et al. Blood. 2004 Nov 1;104(9):2646-54. doi: 10.1182/blood-2003-12-4449. Epub 2004 Jul 13. Blood. 2004. PMID: 15251987 Free article.

2

Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype, and resistance to cyclosporins.

Chen G, Durán GE, Steger KA, Lacayo NJ, Jaffrézou JP, Dumontet C, Sikic BI. Chen G, et al. Among authors: lacayo nj. J Biol Chem. 1997 Feb 28;272(9):5974-82. doi: 10.1074/jbc.272.9.5974. J Biol Chem. 1997. PMID: 9038218 Free article.

3

Loss of cyclosporin and azidopine binding are associated with altered ATPase activity by a mutant P-glycoprotein with deleted phe(335).

Chen KG, Lacayo NJ, Durán GE, Cohen D, Sikic BI. Chen KG, et al. Among authors: lacayo nj. Mol Pharmacol. 2000 Apr;57(4):769-77. doi: 10.1124/mol.57.4.769. Mol Pharmacol. 2000. PMID: 10727524

4

Mitoxantrone, etoposide, and cyclosporine therapy in pediatric patients with recurrent or refractory acute myeloid leukemia.

Dahl GV, Lacayo NJ, Brophy N, Dunussi-Joannopoulos K, Weinstein HJ, Chang M, Sikic BI, Arceci RJ. Dahl GV, et al. Among authors: lacayo nj. J Clin Oncol. 2000 May;18(9):1867-75. doi: 10.1200/JCO.2000.18.9.1867. J Clin Oncol. 2000. PMID: 10784627 Clinical Trial.

5

Pharmacokinetic interactions of cyclosporine with etoposide and mitoxantrone in children with acute myeloid leukemia.

Lacayo NJ, Lum BL, Becton DL, Weinstein H, Ravindranath Y, Chang MN, Bomgaars L, Lauer SJ, Sikic BI, Dahl GV. Lacayo NJ, et al. Leukemia. 2002 May;16(5):920-7. doi: 10.1038/sj.leu.2402455. Leukemia. 2002. PMID: 11986955 Clinical Trial.

6

Preferential expression of a mutant allele of the amplified MDR1 (ABCB1) gene in drug-resistant variants of a human sarcoma.

Chen KG, Lacayo NJ, Durán GE, Wang Y, Bangs CD, Rea S, Kovacs M, Cherry AM, Brown JM, Sikic BI. Chen KG, et al. Among authors: lacayo nj. Genes Chromosomes Cancer. 2002 Aug;34(4):372-83. doi: 10.1002/gcc.10067. Genes Chromosomes Cancer. 2002. PMID: 12112526

7

Modulation of resistance to idarubicin by the cyclosporin PSC 833 (valspodar) in multidrug-resistant cells.

Lacayo NJ, Duran GE, Sikic BI. Lacayo NJ, et al. J Exp Ther Oncol. 2003 May-Jun;3(3):127-35. doi: 10.1046/j.1359-4117.2003.01088.x. J Exp Ther Oncol. 2003. PMID: 14641819

8

Randomized use of cyclosporin A (CsA) to modulate P-glycoprotein in children with AML in remission: Pediatric Oncology Group Study 9421.

Becton D, Dahl GV, Ravindranath Y, Chang MN, Behm FG, Raimondi SC, Head DR, Stine KC, Lacayo NJ, Sikic BI, Arceci RJ, Weinstein H; Pediatric Oncology Group. Becton D, et al. Among authors: lacayo nj. Blood. 2006 Feb 15;107(4):1315-24. doi: 10.1182/blood-2004-08-3218. Epub 2005 Oct 27. Blood. 2006. PMID: 16254147 Free PMC article. Clinical Trial.

9

Low or absent SPARC expression in acute myeloid leukemia with MLL rearrangements is associated with sensitivity to growth inhibition by exogenous SPARC protein.

DiMartino JF, Lacayo NJ, Varadi M, Li L, Saraiya C, Ravindranath Y, Yu R, Sikic BI, Raimondi SC, Dahl GV. DiMartino JF, et al. Among authors: lacayo nj. Leukemia. 2006 Mar;20(3):426-32. doi: 10.1038/sj.leu.2404102. Leukemia. 2006. PMID: 16424866

10

CpG island methylator phenotype and childhood leukemia.

Lacayo NJ, DiMartino JF, Wei MC, Dahl GV. Lacayo NJ, et al. Clin Cancer Res. 2006 Aug 15;12(16):4787-9. doi: 10.1158/1078-0432.CCR-06-0651. Clin Cancer Res. 2006. PMID: 16914562 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

65 results

Search Page